Bone marrow aspirates from patients with AML were analyzed by flow cytometry to measure frequencies of cDCs based on their expression of high levels of CD11c and HLA-DR on their surface (Figure 1A) after gating out non-DC immune cells (Supplementary 2A). This evidence concerns the gene ITGAX and acute myeloid leukemia.